Ph3Core responsibilities: /h3 h3Scientific exchange with HCPs and experts: /h3 ul liEngage in peer‑to‑peer, compliant scientific discussions with KOLs and HCPs (e.g., allergists, ENT, pulmonologists, pediatricians, GPs) on disease state, clinical evidence, guidelines, and appropriate use of ALK therapies. /li liDeliver non‑promotional scientific presentations (1:1 and group) at meetings, clinical sessions, and educational events. /li liSupport scientific advisory boards and educational initiatives to inform clinical evidence needs and advance best practice in patient care. /li liSystematically capture, synthesize, and share field insights (HCPs, reimbursement stakeholders, hospital committees) /li liUse approved materials; document field interactions and insights in approved systems (Veeva). /li liMonitor and communicate scientific developments, competitor clinical evidence, and guideline updates relevant to ALK’s therapeutic areas. /li /ul h3Market access stakeholder engagement (non‑promotional): /h3 ul liMap and cultivate scientific relationships with reimbursement and access stakeholders, including INAMI/RIZIV, mutualities/sickness funds, and hospital formulary/PT committees; engage competent authorities (e.g., AFMPS) for scientific exchange as appropriate, in line with Medical governance and local codes. /li liCommunicate unbiased, evidence‑based clinical value messages derived from the Global/Local Value Dossier, tailored to the needs of payer and access stakeholders. /li liRespond to scientific queries from reimbursement stakeholders and coordinate timely, compliant follow‑up with internal Medical and Market Access colleagues. /li /ul h3Value dossier and scientific support: /h3 ul liContribute to the local adaptation of the Global Value Dossierfor Belgium: ensure the clinical narrative, comparators, endpoints, epidemiology, and care pathways reflect local practice and expectations. /li liCurate, review, and align local clinical literature and guideline updates to support value messaging and access materials under Medical governance. /li liSupport development of scientific briefing documents and FAQs for use in compliant engagements with access stakeholders; ensure consistency and accuracy across materials. /li /ul h3Requirements: /h3 ul libEducation: /b Advanced degree in life sciences (PhD, MD, PharmD, MSc) required. /li libExperience /b: Prior MSL/Medical Affairs experience in pharma/biotech strongly preferred; experience engaging with reimbursement stakeholders in Belgium is a plus. /li libScientific/clinical /b: Strong ability to interpret and communicate clinical evidence; familiarity with immunology/allergy/respiratory is advantageous. /li libCommunication /b: Excellent scientific communication and presentation skills; ability to translate complex clinical evidence into clear, balanced, stakeholder‑appropriate scientific messages. /li libProject management /b: Proven ability to manage cross‑functional projects with multiple stakeholders and timelines. /li libLanguages /b: Fluency in French and English required; proficiency in Dutch preferred (role is Wallonia‑focused but national stakeholder interactions often require Dutch/English). /li libOther /b: Valid driver’s license; willingness to travel 60–70% within Wallonia and to Brussels for national engagements. /li libLocation: /b Belgium (field-based, Wallonia; regular travel to Brussels for national stakeholders) /li /ul /p #J-18808-Ljbffr